Inhibition of SOCS-1 and SOCS-3 in obese diabetic mice improved insulin sensitivity, regulated the expression of SREBP-1c, and ameliorated hepatic steatosis and hypertriglyceridemia [102]. The gene discussed is SREBF1; the disease is Hepatic steatosis.